Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Human Cardiac Organoids for Disease Modeling.

Nugraha B, Buono MF, von Boehmer L, Hoerstrup SP, Emmert MY.

Clin Pharmacol Ther. 2019 Jan;105(1):79-85. doi: 10.1002/cpt.1286. Epub 2018 Dec 21. Review.

PMID:
30415499
2.

Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells.

Yang C, Al-Aama J, Stojkovic M, Keavney B, Trafford A, Lako M, Armstrong L.

Stem Cells. 2015 Sep;33(9):2643-51. doi: 10.1002/stem.2070. Epub 2015 Jun 23. Review.

3.

Forever young: induced pluripotent stem cells as models of inherited arrhythmias.

Park DS, Fishman GI.

Circulation. 2012 Jun 26;125(25):3055-6. doi: 10.1161/CIRCULATIONAHA.112.114165. Epub 2012 May 30. No abstract available.

4.

Development of a Three-Dimensional Bioengineering Technology to Generate Lung Tissue for Personalized Disease Modeling.

Wilkinson DC, Alva-Ornelas JA, Sucre JM, Vijayaraj P, Durra A, Richardson W, Jonas SJ, Paul MK, Karumbayaram S, Dunn B, Gomperts BN.

Stem Cells Transl Med. 2017 Feb;6(2):622-633. doi: 10.5966/sctm.2016-0192. Epub 2016 Sep 15.

5.

Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling.

Eglen RM, Reisine T.

SLAS Technol. 2019 Feb;24(1):18-27. doi: 10.1177/2472630318803275. Review.

PMID:
30798678
6.

Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing.

Shaheen N, Shiti A, Gepstein L.

Clin Pharmacol Ther. 2017 Aug;102(2):203-208. doi: 10.1002/cpt.722. Review.

PMID:
28718902
7.

Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.

Ho BX, Pek NMQ, Soh BS.

Int J Mol Sci. 2018 Mar 21;19(4). pii: E936. doi: 10.3390/ijms19040936. Review.

8.

Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.

Liu C, Oikonomopoulos A, Sayed N, Wu JC.

Development. 2018 Mar 8;145(5). pii: dev156166. doi: 10.1242/dev.156166.

9.

Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease.

Davis RP, Casini S, van den Berg CW, Hoekstra M, Remme CA, Dambrot C, Salvatori D, Oostwaard DW, Wilde AA, Bezzina CR, Verkerk AO, Freund C, Mummery CL.

Circulation. 2012 Jun 26;125(25):3079-91. doi: 10.1161/CIRCULATIONAHA.111.066092. Epub 2012 May 30.

PMID:
22647976
10.

3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.

Lee CT, Bendriem RM, Wu WW, Shen RF.

J Biomed Sci. 2017 Aug 20;24(1):59. doi: 10.1186/s12929-017-0362-8. Review.

11.

Organoid technology for brain and therapeutics research.

Wang Z, Wang SN, Xu TY, Miao ZW, Su DF, Miao CY.

CNS Neurosci Ther. 2017 Oct;23(10):771-778. doi: 10.1111/cns.12754. Review.

12.

Organoid Models and Applications in Biomedical Research.

Xinaris C, Brizi V, Remuzzi G.

Nephron. 2015;130(3):191-9. doi: 10.1159/000433566. Epub 2015 Jun 25. Review.

13.

Rapid Induction of Cerebral Organoids From Human Induced Pluripotent Stem Cells Using a Chemically Defined Hydrogel and Defined Cell Culture Medium.

Lindborg BA, Brekke JH, Vegoe AL, Ulrich CB, Haider KT, Subramaniam S, Venhuizen SL, Eide CR, Orchard PJ, Chen W, Wang Q, Pelaez F, Scott CM, Kokkoli E, Keirstead SA, Dutton JR, Tolar J, O'Brien TD.

Stem Cells Transl Med. 2016 Jul;5(7):970-9. doi: 10.5966/sctm.2015-0305. Epub 2016 May 13.

14.

Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.

Mun SJ, Ryu JS, Lee MO, Son YS, Oh SJ, Cho HS, Son MY, Kim DS, Kim SJ, Yoo HJ, Lee HJ, Kim J, Jung CR, Chung KS, Son MJ.

J Hepatol. 2019 Nov;71(5):970-985. doi: 10.1016/j.jhep.2019.06.030. Epub 2019 Jul 9.

PMID:
31299272
15.

Neural organoids for disease phenotyping, drug screening and developmental biology studies.

Hartley BJ, Brennand KJ.

Neurochem Int. 2017 Jun;106:85-93. doi: 10.1016/j.neuint.2016.10.004. Epub 2016 Oct 12. Review.

16.

Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders.

Nelson BC, Hashem SI, Adler ED.

Curr Cardiol Rep. 2017 Mar;19(3):26. doi: 10.1007/s11886-017-0829-y. Review.

PMID:
28251514
17.

Modeling of Autism Using Organoid Technology.

Choi H, Song J, Park G, Kim J.

Mol Neurobiol. 2017 Dec;54(10):7789-7795. doi: 10.1007/s12035-016-0274-8. Epub 2016 Nov 14. Review.

PMID:
27844287
18.

Disease Modeling in Stem Cell-Derived 3D Organoid Systems.

Dutta D, Heo I, Clevers H.

Trends Mol Med. 2017 May;23(5):393-410. doi: 10.1016/j.molmed.2017.02.007. Epub 2017 Mar 21. Review.

PMID:
28341301
19.

Modeling heart disease in a dish: from somatic cells to disease-relevant cardiomyocytes.

Zanella F, Lyon RC, Sheikh F.

Trends Cardiovasc Med. 2014 Jan;24(1):32-44. doi: 10.1016/j.tcm.2013.06.002. Epub 2013 Sep 17. Review.

20.

The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.

Ye L, Ni X, Zhao ZA, Lei W, Hu S.

J Cardiovasc Transl Res. 2018 Oct;11(5):366-374. doi: 10.1007/s12265-018-9811-3. Epub 2018 May 29. Review.

PMID:
29845439

Supplemental Content

Support Center